Hospitals’ pharmacy spending is projected to rise by 3.42% next year, according to a new report published by Vizient. Specialty drugs and neurology medications are the primary drivers of this increase in pharmacy expenses.
Vizient…
Specialty medications are often used to treat complex diseases, many times in life-saving situations. But the robust process to onboard a patient on a specialty medication highlights an urgent need to modernize healthcare technology,…
Continue Reading
The past year has been filled with rapid advancements in generative AI, which refers to AI that can produce content like text, imagery and audio. While the healthcare sector has a reputation of being…
Continue Reading
The continued maturation of decentralized clinical trials (DCTs) has given researchers the ability to securely collect real-world data on patients as they go about their daily routines. This broader access provides us with new,…
Continue Reading
The consensus is 2022 was a challenging year for digital health companies. Venture capital and other startup investment in the U.S. digital health sector plummeted to $15 billion from more than $29 billion in…
Continue Reading
One of the fastest-growing frontiers of healthcare is Digital Therapeutics (DTx), which utilizes clinically tested software to prevent, treat, and manage a growing range of medical conditions. During Covid-19, governing agencies loosened regulatory requirements…
Continue Reading
Historically, the majority of healthcare services and products have been available to the general public offline, but as the world has become increasingly digital, so has our approach to healthcare. In the ‘digital age’…
Continue Reading
As the healthcare industry strives toward precision medicine, it will be essential for care providers to gain an intimate view of a patient’s response to treatment to determine its impact on their quality of…
Continue Reading
As of April 2023, the number of recruiting studies in the US was 24,138. Based on FDA data from new drug approvals in 2021, we can assume an average of 760 patients are needed…
Continue Reading
The FDA’s new draft guidance on Decentralized Clinical Trials (DCTs) is a landmark moment for the industry, emphasizing the importance of virtual trials for improving patient access to groundbreaking research while providing recommendations on…
Continue Reading
